Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis

Chenyu Zhao,Yunyuan Yu,Guangrong Yin,Chao Xu,Jiahao Wang,Liangliang Wang,Gongyin Zhao,Su Ni,Haoxing Zhang,Baojun Zhou,Yuji Wang
DOI: https://doi.org/10.1007/s10787-024-01439-6
2024-02-28
Inflammopharmacology
Abstract:Ferroptosis has been reported to play a role in rheumatoid arthritis (RA). Sulfasalazine, a common clinical treatment for ankylosing spondylitis, also exerts pathological influence on the progression of rheumatoid arthritis including the induced ferroptosis of fibroblast-like synoviocytes (FLSs), which result in the perturbated downstream signaling and the development of RA. The aim of this study was to investigate the underlying mechanism so as to provide novel insight for the treatment of RA.
immunology,toxicology
What problem does this paper attempt to address?